The Patient's Guide to Psoriasis Treatment. Part 4: Goeckerman Therapy

Tian Hao Zhu, Mio Nakamura, Benjamin Farahnik, Michael Abrouk, Rasnik K Singh, Kristina M Lee, Sarah Hulse, John Koo, Tina Bhutani, Wilson Liao, Tian Hao Zhu, Mio Nakamura, Benjamin Farahnik, Michael Abrouk, Rasnik K Singh, Kristina M Lee, Sarah Hulse, John Koo, Tina Bhutani, Wilson Liao

Abstract

Background: The Goeckerman regimen remains one of the oldest, most reliable treatment options for patients with moderate to severe psoriasis. Goeckerman therapy currently consists of exposure to ultraviolet B light and application of crude coal tar. The details of the procedure can be confusing and challenging to understand for the first-time patient or provider.

Objective: To present a freely available online guide and video on Goeckerman treatment that explains the regimen in a patient-oriented manner.

Methods: The Goeckerman protocol used at the University of California-San Francisco Psoriasis and Skin Treatment Center as well as available information from the literature were reviewed to design a comprehensive guide for patients receiving Goeckerman treatment.

Results: We created a printable guide and video resource that covers the supplies needed for Goeckerman regimen, the treatment procedure, expected results, how to monitor for adverse events, and discharge planning.

Conclusion: This new resource is beneficial for prospective patients planning to undergo Goeckerman treatment, healthcare providers, and trainees who want to learn more about this procedure. Online media and video delivers material in a way that is flexible and often familiar to patients.

Keywords: Goeckerman therapy; Patient education; Psoriasis; Tar; Video guide.

Figures

Fig. 1
Fig. 1
Supplies for Goeckerman regimen. Left side gown, socks, shower cap. Top row Mineral oil, Aquaphilic ointment, Vanicream, plastic wrap. Middle row 20% liquid carbonis detergens in Vanicream lotion, 20% liquid carbonis detergens in Aquaphor ointment, 5% crude coal tar in white petrolatum ointment, triamcinolone 0.01% ointment. Bottom row Desonide 0.05% ointment, clobetasol propionate 0.05% ointment
Fig. 2
Fig. 2
Treatment procedure. a Nurse occluding tar with plastic wrap. b Patient spends 4–5 h in waiting area during tar therapy

References

    1. Gupta R, Debbaneh M, Butler D, et al. The Goeckerman regimen for the treatment of moderate to severe psoriasis. J Vis Exp 2013;(77):e50509. doi:10.3791/50509.
    1. Perry HO, Soderstrom CW, Schulze RW. The Goeckerman treatment of psoriasis. Arch Dermatol. 1968;98(2):178–182. doi: 10.1001/archderm.1968.01610140076019.
    1. Goeckerman WH. The treatment of psoriasis. Northwest Med. 1925;24:229–230.
    1. Parrish JA, Morison WL, Gonzalez E, Krop TM, White HA, Rosario R. Therapy of psoriasis by tar photosensitization. J Invest Dermatol. 1978;70(2):111–112. doi: 10.1111/1523-1747.ep12541245.
    1. Le Vine MJ, White HA, Parrish JA. Components of the Goeckerman regimen. J Invest Dermatol. 1979;73(2):170–173. doi: 10.1111/1523-1747.ep12581626.
    1. Menter A, Cram D. The Goeckerman regimen in two psoriasis day care centers. J Am Acad Dermatol. 1983;9(1):59–65. doi: 10.1016/S0190-9622(83)70107-6.
    1. Storan E, McEvoy M, Wetter D, et al. Filling a critical practice gap: experience with a dermatology day treatment center at Mayo Clinic. Int J Dermatol. 2014;54(5):600–604. doi: 10.1111/ijd.12617.
    1. Lee E, Koo J. Modern modified “ultra” Goeckerman therapy: a PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies. J Dermatol Treat. 2005;16(2):102–107. doi: 10.1080/09546630510033140.
    1. Koo J, Lebwohl M. Duration of remission of psoriasis therapies. J Am Acad Dermatol. 1999;41(1):51–59. doi: 10.1016/S0190-9622(99)70406-8.
    1. Ho J, Chern E, Yau D, et al. Positive effect of modified Goeckerman regimen on quality of life and psychosocial distress in moderate and severe psoriasis. Acta Dermato Venereol. 2011;91(4):447–451. doi: 10.2340/00015555-1096.
    1. Dennis M, Bhutani T, Koo J, Liao W. Goeckerman therapy for the treatment of eczema: a practical guide and review of efficacy. J Dermatol Treat. 2011;24(1):2–6. doi: 10.3109/09546634.2011.607794.
    1. Sorenson E, Levin E, Koo J, Berger TG. Successful use of a modified Goeckerman regimen in the treatment of generalized prurigo nodularis. J Am Acad Dermatol. 2015;72(1):e40–e42. doi: 10.1016/j.jaad.2014.09.050.
    1. Roelofzen J, Aben K, Oldenhof U, et al. No increased risk of cancer after coal tar treatment in patients with psoriasis or eczema. J Invest Dermatol. 2009;130(4):953–961. doi: 10.1038/jid.2009.389.
    1. Madan R, Levitt J. A review of toxicity from topical salicylic acid preparations. J Am Acad Dermatol. 2014;70(4):788–792. doi: 10.1016/j.jaad.2013.12.005.
    1. Pittelkow M, Perry H, Muller S, Maughan W, O’Brien P. Skin cancer in patients with psoriasis treated with coal tar: a 25-year follow-up study. Arch Dermatol. 1981;117(8):465–468. doi: 10.1001/archderm.1981.01650080019020.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel